Tax dollars are making it easier for the drug and diagnostics industry to develop and market essential TB products. Is the public getting a fair return on its investment?  

South Africa has about 18% of the global burden of laboratory-confirmed MDR tuberculosis and the highest number of confirmed XDR cases.

Confirming the efficacy and safety of bedaquiline-inclusive regimens is a priority. Comparing them to unvalidated MDR-TB drug combinations in the planned STREAM study is not the way to go about it.

With EU elections coming up soon, there is a great opportunity for the new European Institutions to take concrete initiatives on drug-resistant tuberculosis: the only ingredient missing so far is political will.

Report, titled "The fight against tuberculosis", discusses the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to be done at a European level to tackle this preventable disease.

Two government reports published in March show that the nation’s health is improving dramatically, but more people are getting sick from forms of tuberculosis that are difficult to treat.

First edition of Standards for TB Care in India released by Central TB Division, Government of India on World TB Day (24 March 2014).

Lesotho, Mozambique, Swaziland, Zimbabwe, South Africa, Zambia, Malawi, Tanzania and Namibia agreed to go towards a regional harmonization approach in addressing tuberculosis in mining.

Representatives from across the G7 and the European Parliament have released a statement calling for a renewed global commitment to “drive down rates of TB across the world and to accelerate progress towards ending TB as a threat to global public health.”

The study is the most robust ever conducted into how smoking tobacco increases the risk of recurrent TB.